Skip to content

Multiple Myeloma as Monotherapy for Maintenance Treatment After Autologous Stem Cell Transplantation

A selection of medicines used for Multiple Myeloma as Monotherapy for Maintenance Treatment After Autologous Stem Cell Transplantation is listed below, including Lenalidomide. Products containing Lenalidomide feature in this group. Prices and product details are shown for comparison.

Lenalidomide Capsules

Lenalidomide

10mg

Treats multiple myeloma, myelodysplastic syndromes and certain lymphomas by modulating the immune system and directly targeting tumour cells, resulting in reduced cancer cell proliferation.

From$20.03/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.